Delivery Order SPE2DR25D1017-SPE2DR26F9ARK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Posaconazole DR 100 mg tablets (60-count units) valued at $1,584.10. This firm fixed-price delivery order, which must be completed by September 18, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $7,911.53 to AmerisourceBergen Drug Corp for the supply of Posaconazole DR 100 mg tablets (60-count units) on July 25, 2025, with completion targeted for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Posaconazole DR 100 mg tablets in unit dose packaging of 20 tablets, with a contract value of $10,613.09. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,961.60 to AmerisourceBergen Drug Corp for Posaconazole 200 mg/5 ml Suspension (105ml) on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 60 tablets of Posaconazole 100 mg, an antifungal medication commonly used in military and federal healthcare settings. The contract, valued at $1,046.68 with a firm fixed price structure, was awarded on September 26, 2025, and carries an ultimate completion date of September 29, 2025. The award represents a non-competitive, non-set-aside delivery order, and performance will be fulfilled from...
- The Defense Logistics Agency awarded a $2,055.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Posaconazole 300 mg/16.7 ml vials. The contract, with an ultimate completion date of July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. This award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Posaconazole 200 mg/5 mL suspension (105 mL) with a ceiling value of $3,727.32. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 24, 2025. The award was issued on July 23, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $2,093.73 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Posaconazole 100 mg, an antifungal medication commonly used in military and veteran healthcare settings. This competitively awarded, firm fixed-price contract was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $4,288.58 to AmerisourceBergen Drug Corp for the supply of Posaconazole 300 mg/16.7 mL vials on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery transaction under AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Posaconazole delayed-release 100 mg tablets. The contract, valued at $1,106.69, has a period of performance through July 26, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9ARKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Posaconazole DR 100 mg tablets (60-count units) with a ceiling value of $1,199.24. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to complete by December 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support defense health requirements. The delivery order for Posaconazole, an antifungal medication, represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare system customers through the established prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/1/25 |